Walking for Stress Reduction

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Benno Brinkhaus, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01716832
First received: October 24, 2012
Last updated: October 29, 2012
Last verified: October 2012
  Purpose

The effectiveness of a mindfulness walking program is tested in subjects with a high level of subjectively perceived stress.


Condition Intervention
Healthy Subjects.
Behavioral: Mindfulness Walking

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effectiveness of Mindfulness Walking on Stress Reduction

Further study details as provided by Charite University, Berlin, Germany:

Primary Outcome Measures:
  • Cohens Perceived Stress Scale 14 Items [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Quality of Life (SF 36) [ Time Frame: Baseline, 4 weeks, 12 weeks ] [ Designated as safety issue: No ]
  • Subjective Stress Level (Visual Analogue Scale) [ Time Frame: Baseline, 4 weeks, 12 weeks ] [ Designated as safety issue: No ]
  • Assessment of effect on a Likert - Scale [ Time Frame: 4 weeks, 12 weeks ] [ Designated as safety issue: No ]

Enrollment: 74
Study Start Date: March 2011
Study Completion Date: November 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Mindfulness walking Behavioral: Mindfulness Walking
Mindful walking in a small group twice a week for 60 minutes within 4 weeks.
No Intervention: No intervention (waiting list)

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy men and women between 18 and 65 years
  • Increased level of stress (visual analog scale >40 mm (0-100))

Exclusion Criteria:

  • Regular walking training in the last 6 weeks
  • Medical therapy with psychopharmacological drugs
  • Regular mindfulness based meditations/exercises in the last 6 weeks
  • CAM therapies against stress in the last 6 weeks
  • medium or severe chronic diseases
  • Stress due to chronic diseases
  • Acute disease at inclusion
  • Not being able to walk
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01716832

Locations
Germany
Charité University Berlin
Berlin, Germany, 10117
Sponsors and Collaborators
Charite University, Berlin, Germany
  More Information

No publications provided

Responsible Party: Benno Brinkhaus, Prof. MD, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier: NCT01716832     History of Changes
Other Study ID Numbers: Walking_Stress_Reduction
Study First Received: October 24, 2012
Last Updated: October 29, 2012
Health Authority: Germany: Ethics Commission

ClinicalTrials.gov processed this record on July 22, 2014